RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88–101 (Englisch)
- Neue Suche nach: Wallis, Christopher J.D.
- Neue Suche nach: Klaassen, Zachary
- Neue Suche nach: Wallis, Christopher J.D.
- Neue Suche nach: Klaassen, Zachary
In:
European journal of cancer
;
94
;
216-217
;
2018
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88–101
-
Beteiligte:Wallis, Christopher J.D. ( Autor:in ) / Klaassen, Zachary ( Autor:in )
-
Erschienen in:European journal of cancer ; 94 ; 216-217
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2018
-
Format / Umfang:2 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.994
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.994 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 94
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Assessing the prognostic value of carcinoembryonic antigen levels in stage I and II colon cancerMargalit, Ofer / Mamtani, Ronac / Yang, Yu-Xiao / Reiss, Kim A. / Golan, Talia / Halpern, Naama / Aderka, Dan / Giantonio, Bruce / Shacham-Shmueli, Einat / Boursi, Ben et al. | 2018
- 6
-
The impact of overdiagnosis on thyroid cancer epidemic in Italy, 1998–2012Dal Maso, Luigino / Panato, Chiara / Franceschi, Silvia / Serraino, Diego / Buzzoni, Carlotta / Busco, Susanna / Ferretti, Stefano / Torrisi, Antonietta / Falcini, Fabio / Zorzi, Manuel et al. | 2018
- 16
-
Intermediate prognosis in metastatic germ cell tumours—outcome and prognostic factorsSeidel, Christoph / Daugaard, Gedske / Tryakin, Alexey / Necchi, Andrea / Cohn Cedermark, Gabriella / Ståhl, Olof / Hentrich, Marcus / Brito, Margarida / Albany, Costantine / Taza, Fadi et al. | 2018
- 26
-
Management of hyperbilirubinaemia in pancreatic cancer patientsÁlvarez, R. / Carrato, A. / Adeva, J. / Alés, I. / Prados, S. / Valladares, M. / Macarulla, T. / Muñoz, A. / Hidalgo, M. et al. | 2018
- 37
-
Aflatoxin B1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumptionChu, Yu-Ju / Yang, Hwai-I / Wu, Hui-Chen / Lee, Mei-Hsuan / Liu, Jessica / Wang, Li-Yu / Lu, Sheng-Nan / Jen, Chin-Lan / You, San-Lin / Santella, Regina M. et al. | 2018
- 47
-
The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: An international assessmentStang, Andreas / Becker, Jürgen C. / Nghiem, Paul / Ferlay, Jacques et al. | 2018
- 61
-
Does smoking alter the mutation profile of human papillomavirus–driven head and neck cancers?Mirghani, Haitham / Lacroix, Ludovic / Rossoni, Caroline / Sun, Roger / Aupérin, Anne / Casiraghi, Odile / Villepelet, Aude / Lacave, Roger / Faucher, Gladwys / Marty, Virginie et al. | 2018
- 70
-
Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01/04) studyWilson, C. / Bell, R. / Hinsley, S. / Marshall, H. / Brown, J. / Cameron, D. / Dodwell, D. / Coleman, R. et al. | 2018
- 79
-
A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)Lindman, H. / Andersson, M. / Ahlgren, J. / Balslev, E. / Sverrisdottir, A. / Holmberg, S.B. / Bengtsson, N.O. / Jacobsen, E.H. / Jensen, A.B. / Hansen, J. et al. | 2018
- 87
-
Efficacy of tivozanib treatment after sorafenib in patients with advanced renal cell carcinoma: crossover of a phase 3 studyMolina, Ana M. / Hutson, Thomas E. / Nosov, Dmitry / Tomczak, Piotr / Lipatov, Oleg / Sternberg, Cora N. / Motzer, Robert / Eisen, Tim et al. | 2018
- 95
-
Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the 'Arbeitsgemeinschaft Internistische Onkologie'Haas, M. / Siveke, J.T. / Schenk, M. / Lerch, M.M. / Caca, K. / Freiberg-Richter, J. / Fischer von Weikersthal, L. / Kullmann, F. / Reinacher-Schick, A. / Fuchs, M. et al. | 2018
- 104
-
Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre studyHewitt, L.C. / Inam, I.Z. / Saito, Y. / Yoshikawa, T. / Quaas, A. / Hoelscher, A. / Bollschweiler, E. / Fazzi, G.E. / Melotte, V. / Langley, R.E. et al. | 2018
- 115
-
Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival updateChoueiri, Toni K. / Hessel, Colin / Halabi, Susan / Sanford, Ben / Michaelson, M. Dror / Hahn, Olwen / Walsh, Meghara / Olencki, Thomas / Picus, Joel / Small, Eric J. et al. | 2018
- 126
-
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trialCardinale, Daniela / Ciceri, Fabio / Latini, Roberto / Franzosi, Maria Grazia / Sandri, Maria Teresa / Civelli, Maurizio / Cucchi, GianFranco / Menatti, Elisabetta / Mangiavacchi, Maurizio / Cavina, Raffaele et al. | 2018
- 138
-
Long-term survival improvement in oesophageal cancer in the Netherlandsvan Putten, M. / de Vos-Geelen, J. / Nieuwenhuijzen, G.A.P. / Siersema, P.D. / Lemmens, V.E.P.P. / Rosman, C. / van der Sangen, M.J.C. / Verhoeven, R.H.A. et al. | 2018
- 148
-
Interventional radiology: Role in the treatment of sarcomasde Baere, Thierry / Tselikas, Lambros / Gravel, Guillaume / Hakime, Antoine / Deschamps, Frederic / Honoré, Charles / Mir, Olivier / Lecesne, Axel et al. | 2018
- 156
-
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'Schöffski, Patrick / Wozniak, Agnieszka / Leahy, Michael G. / Aamdal, Steinar / Rutkowski, Piotr / Bauer, Sebastian / Richter, Stephan / Grünwald, Viktor / Debiec-Rychter, Maria / Sciot, Raf et al. | 2018
- 168
-
Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trialGao, Y. / Weenink, B. / van den Bent, M.J. / Erdem-Eraslan, L. / Kros, J.M. / Sillevis Smitt, PAE / Hoang-Xuan, K. / Brandes, A.A. / Vos, M. / Dhermain, F. et al. | 2018
- 179
-
Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapyGatalica, Zoran / Xiu, Joanne / Swensen, Jeff / Vranic, Semir et al. | 2018
- 187
-
Prognostic relevance of distant metastases versus locally advanced disease in soft tissue sarcomas: An EORTC-STBSG database studyVerschoor, A.J. / Litière, S. / Marréaud, S. / Judson, I. / Toulmonde, M. / Wardelmann, E. / van der Graaf, W.T. / Le Cesne, A. / Gronchi, A. / Gelderblom, H. et al. | 2018
- 199
-
Outcomes of single versus double hormone receptor–positive breast cancer. A GEICAM/9906 sub-studyEthier, J.L. / Ocaña, A. / Rodríguez Lescure, A. / Ruíz, A. / Alba, E. / Calvo, L. / Ruíz-Borrego, M. / Santaballa, A. / Rodríguez, C.A. / Crespo, C. et al. | 2018
- 206
-
Health-related quality of life from the FALCON phase III randomised trial of fulvestrant 500 mg versus anastrozole for hormone receptor-positive advanced breast cancerRobertson, John F.R. / Cheung, Kwok-Leung / Noguchi, Shinzaburo / Shao, Zhimin / Degboe, Arnold / Lichfield, Jasmine / Thirlwell, Jackie / Fazal, Mehdi / Ellis, Matthew J. et al. | 2018
- 216
-
RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88–101Wallis, Christopher J.D. / Klaassen, Zachary et al. | 2018
- 218
-
Response to letter commenting on published paper: Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysisRydzewska, Larysa H.M. / Burdett, Sarah / Vale, Claire L. / Parmar, Mahesh K.B. / Tierney, Jayne F. et al. | 2018